Clinical Trial Update: Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous Thromboembolism [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating antithrombin to improve thromboprophylaxis and reduce trauma-related venous thromboembolism; currently enrolling by invitation…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Antithrombin (antithrombin)

Snippet

Sponsor: Bryan Cotton | Conditions: Trauma Injury, Thromboembolism | Phase 2 | Status: ENROLLING_BY_INVITATION